Compositions and methods for vaccinating against HSV-2

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S006120

Reexamination Certificate

active

07628993

ABSTRACT:
This invention relates to a method for systemic immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune response in a mammal. The method is particularly effective for protecting a mammal from herpes simplex virus. Also disclosed are therapeutic compositions useful in such a method.

REFERENCES:
patent: 5654174 (1997-08-01), Cohen et al.
patent: 6375952 (2002-04-01), Koelle et al.
patent: 6413518 (2002-07-01), Koelle et al.
patent: 6814969 (2004-11-01), Koelle et al.
patent: 6855317 (2005-02-01), Koelle et al.
patent: 7037509 (2006-05-01), Koelle et al.
patent: 7078041 (2006-07-01), Koelle et al.
patent: 2005/0163794 (2005-07-01), Koelle et al.
patent: 2006/0216304 (2006-09-01), Koelle et al.
patent: WO00/57917 (2000-10-01), None
patent: WO01/32221 (2001-05-01), None
patent: WO03/104400 (2003-12-01), None
Nakamura et al, Nucleic Acid Research, 2000, 28: 292.
Dong, L, et al. “Cellular and humoral immune responses to HSV-2 tegument proteins in H-2D mice after DNA vaccination”,31st International Herpesvirus Workshop, Seattle, WA, Jul. 22-27, 2006, Abstract 9.16.
Ferrari, Marilyn E., et al. “Synergy between cationic lipid and co-lipid determines the macroscopic structure and transfection activity of lipoplexes”,Nucleic Acids Research(2002) 30(8):1808-1816.
Muller, W., et al. “Cellular and humoral immune responses induced by Plasmid DNA vaccines encoding HSV-2 Tegument Proteins”,44th Annual Meeting of the Infectious Diseases Society of America(IDSA), Toronto, Canada, Oct. 12-15, 2006, Abstract 615, p. 166.
Muller, W.J., et al. “HSV-2 tegument directed T-cells develop after vaginal infection in Balb/c mice and tegument-based vaccines partially protect against lethal challenge”,32nd International Herpesvirus Workshop, Asheville, NC, Jul. 2007, Abstract 10.20.
Koelle, D.M., et al. “Immunogenicity and protective efficacy of plasmid DNA vaccines encoding HSV-2 tegument proteins in a murine intravaginal challenge model”,17th International Society of Sexually Transmitted Diseases Research(ISSTDR), Seattle, WA, Jul. 2007, Abstract 317.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Compositions and methods for vaccinating against HSV-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for vaccinating against HSV-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for vaccinating against HSV-2 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4071933

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.